Search Results for "erythromycin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for erythromycin. Results 11 to 12 of 12 total matches.
Elinzanetant (Lynkuet) for Menopausal Vasomotor Symptoms
The Medical Letter on Drugs and Therapeutics • Dec 22, 2025 (Issue 1744)
of elinzanetant should be reduced
when it is used with a moderate CYP3A4 inhibitor (e.g.,
erythromycin ...
Elinzanetant (Lynkuet – Bayer), a first-in-class
neurokinin 1 (NK1) and neurokinin 3 (NK3) receptor
antagonist, has been approved by the FDA for
treatment of moderate to severe vasomotor symptoms
(VMS) due to menopause. Fezolinetant (Veozah), an
NK3 receptor antagonist, was approved for the same
indication in 2023.
Med Lett Drugs Ther. 2025 Dec 22;67(1744):203-6 doi:10.58347/tml.2025.1744b | Show Introduction Hide Introduction
Drugs for COPD
The Medical Letter on Drugs and Therapeutics • Sep 02, 2024 (Issue 1710)
these
enzymes, such as cimetidine, erythromycin,
The Medical Letter ® Vol. 66 (1710) September 2, 2024
142 ...
The main goals of treatment of chronic obstructive
pulmonary disease (COPD) are to relieve symptoms,
reduce the frequency and severity of exacerbations,
prevent disease progression, and reduce mortality.
GOLD (Global Initiative for Chronic Obstructive Lung
Disease) guidelines for treatment of COPD were
updated recently. Treatment of acute exacerbations
is not discussed here. Drugs available for treatment
of COPD are listed in Tables 1 and 3.
Med Lett Drugs Ther. 2024 Sep 2;66(1710):137-44 doi:10.58347/tml.2024.1710a | Show Introduction Hide Introduction